Authenticx Announces $20M in Series B Funding to Enhance the Customer Journey

Authenticx, the new standard in healthcare for listening to customer voices at scale, today announced $20M in Series B funding led by Blue Heron Capital with participation from Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures and M25.

The investment comes after a significant year of growth for Authenticx, which saw a 2.5x increase in ARR in 2022 and 64 new employees since July 2021, many of whom joined product innovation and sales departments. Additionally, Authenticx's customer base doubled over the last year, with its client portfolio now including five of the top 10 leading global pharmaceutical companies.

"By listening at scale, business leaders can feel confident that the strategies they implement in their organization are backed by data generated from the authentic words of their customers," said Amy Brown, CEO of Authenticx. "Whether identifying areas of frustration for customers or listening for good news, conversational data can be used to revolutionize the patient experience and remind the workforce of their noble purpose. With this funding, we'll be able to continue driving innovation in conversational intelligence and machine learning to streamline the patient journey and help staff do their best work."

Authenticx is the first investment out of MCPF IV. Read more about the funding here